Judge: Investors Failed To Link Stock Drop To Biotech Company’s Misstatements

SAN DIEGO — A federal judge in California granted a biotechnology company and its subsidiary’s motion to dismiss a securities fraud class action brought by investors alleging that the companies provided...

Already a subscriber? Click here to view full article